Intuitive Surgical, Inc. ISRG
405.18
5.66
1.42%
as of 25 Sep
- Market cap
- $140.7B
- P/E
- 45.8×
Follow ISRG
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Intuitive Surgical, Inc. (ISRG) P/E ratio
As of 25 September 2026, Intuitive Surgical, Inc. (ISRG) trades at a P/E ratio of 45.8×. Over the past ten years it has ranged from 30.7× (October 2015) to 93.5× (January 2025); the current reading is higher than 27% of that period. That is above the Medical Instruments & Supplies industry median of 34.2× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 70.7× | (11.54%) |
| FY2024 | 79.9× | 23.41% |
| FY2023 | 64.8× | (9.29%) |
| FY2022 | 71.4× | (4.87%) |
| FY2021 | 75.1× | (16.87%) |
| FY2020 | 90.3× | 82.69% |
| FY2019 | 49.4× | 2.48% |
| FY2018 | 48.2× | (23.99%) |
| FY2017 | 63.5× | 89.34% |
| FY2016 | 33.5× | (2.67%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 45.0× | (18.32%) |
| Mar 2026 | 55.1× | (22.11%) |
| Dec 2025 | 70.7× | 21.58% |
| Sep 2025 | 58.2× | (21.87%) |
| 42 more quarters | Free account |
Against its own ten years
Low 30.7×
High 93.5×
Ten-year median
60.4×
Current reading's percentile
27
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| SOLV Solventum Corporation compare | 10.9× |
| RMD ResMed Inc. compare | 21.3× |
| ISRG Intuitive Surgical, Inc. | 45.8× |
| WST West Pharmaceutical Services, Inc. compare | 47.1× |
| ALC Alcon compare | 49.2× |
| BDX Becton, Dickinson and Company compare | 55.4× |
| RGEN Repligen Corporation compare | 253× |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 34.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ISRG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement